Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Gut Microbiota Modulation by Dietary Barley Malt Melanoidins.

Aljahdali N, Gadonna-Widehem P, Anton PM, Carbonero F.

Nutrients. 2020 Jan 17;12(1). pii: E241. doi: 10.3390/nu12010241.

2.

Increases in HIV Incidence Following Receptive Anal Intercourse Among Women: A Systematic Review and Meta-analysis.

Stannah J, Silhol R, Elmes J, Owen B, Shacklett BL, Anton P, McGowan I, van der Straten A, Dimitrov D, Baggaley RF, Boily MC.

AIDS Behav. 2020 Mar;24(3):667-681. doi: 10.1007/s10461-019-02651-0.

3.

A consensus S. cerevisiae metabolic model Yeast8 and its ecosystem for comprehensively probing cellular metabolism.

Lu H, Li F, Sánchez BJ, Zhu Z, Li G, Domenzain I, Marcišauskas S, Anton PM, Lappa D, Lieven C, Beber ME, Sonnenschein N, Kerkhoven EJ, Nielsen J.

Nat Commun. 2019 Aug 8;10(1):3586. doi: 10.1038/s41467-019-11581-3.

4.

Prevention of Adult Colitis by Oral Ferric Iron in Juvenile Mice Is Associated with the Inhibition of the Tbet Promoter Hypomethylation and Gene Overexpression.

Ettreiki C, Chango A, Barbezier N, Coeffier M, Anton PM, Delayre-Orthez C.

Nutrients. 2019 Jul 31;11(8). pii: E1758. doi: 10.3390/nu11081758.

5.

Human Vault Nanoparticle Targeted Delivery of Antiretroviral Drugs to Inhibit Human Immunodeficiency Virus Type 1 Infection.

Fulcher JA, Tamshen K, Wollenberg AL, Kickhoefer VA, Mrazek J, Elliott J, Ibarrondo FJ, Anton PA, Rome LH, Maynard HD, Deming T, Yang OO.

Bioconjug Chem. 2019 Aug 21;30(8):2216-2227. doi: 10.1021/acs.bioconjchem.9b00451. Epub 2019 Jul 16.

PMID:
31265254
6.

What Proportion of Female Sex Workers Practise anal Intercourse and How Frequently? A Systematic Review and Meta-analysis.

Owen BN, Baggaley RF, Elmes J, Harvey A, Shubber Z, Butler AR, Silhol R, Anton P, Shacklett B, van der Straten A, Boily MC.

AIDS Behav. 2020 Mar;24(3):697-713. doi: 10.1007/s10461-019-02477-w. Review.

7.

The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM.

McGowan I, Wilkin T, Landovitz RJ, Wu C, Chen Y, Marzinke MA, Hendrix CW, Richardson P, Eshleman SH, Andrade A, Chege W, Anderson PL, McCauley M, Farley J, Mayer KH, Anton P, Brand RM, Cranston RD, Gulick R.

AIDS. 2019 Feb 1;33(2):237-246. doi: 10.1097/QAD.0000000000002038.

8.

Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.

Vincent KL, Moss JA, Marzinke MA, Hendrix CW, Anton PA, Pyles RB, Guthrie KM, Dawson L, Olive TJ, Butkyavichene I, Churchman SA, Cortez JM Jr, Fanter R, Gunawardana M, Miller CS, Yang F, Rosen RK, Vargas SE, Baum MM.

PLoS Med. 2018 Sep 28;15(9):e1002655. doi: 10.1371/journal.pmed.1002655. eCollection 2018 Sep.

9.

Does per-act HIV-1 transmission risk through anal sex vary by gender? An updated systematic review and meta-analysis.

Baggaley RF, Owen BN, Silhol R, Elmes J, Anton P, McGowan I, van der Straten A, Shacklett B, Dang Q, Swann EM, Bolton DL, Boily MC.

Am J Reprod Immunol. 2018 Nov;80(5):e13039. doi: 10.1111/aji.13039. Epub 2018 Sep 2.

10.

Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc.

Vincent KL, Moss JA, Marzinke MA, Hendrix CW, Anton PA, Gunawardana M, Dawson LN, Olive TJ, Pyles RB, Baum MM.

PLoS One. 2018 Aug 22;13(8):e0201952. doi: 10.1371/journal.pone.0201952. eCollection 2018.

11.

Highly Attenuated Infection With a Vpr-Deleted Molecular Clone of Human Immunodeficiency Virus-1.

Ali A, Ng HL, Blankson JN, Burton DR, Buckheit RW 3rd, Moldt B, Fulcher JA, Ibarrondo FJ, Anton PA, Yang OO.

J Infect Dis. 2018 Sep 22;218(9):1447-1452. doi: 10.1093/infdis/jiy346.

12.

A Nurse-Led Mobility Program on an Acute Rehabilitation Unit.

Anton P, Richard C.

Crit Care Nurs Q. 2018 Jul/Sep;41(3):282-288. doi: 10.1097/CNQ.0000000000000207.

PMID:
29851677
13.

Integrating a Standardized Mobility Program and Safe Patient Handling.

Dickinson S, Taylor S, Anton P.

Crit Care Nurs Q. 2018 Jul/Sep;41(3):240-252. doi: 10.1097/CNQ.0000000000000202.

PMID:
29851673
14.

Comparative Assessment of Small and Large Intestine Biopsies for Ex Vivo HIV-1 Pathogenesis Studies.

Elliott J, Fulcher JA, Ibarrondo FJ, Tanner K, McGowan I, Anton PA.

AIDS Res Hum Retroviruses. 2018 Oct;34(10):900-906. doi: 10.1089/AID.2017.0249. Epub 2018 May 16.

15.

Brief Report: Recent Methamphetamine Use Is Associated With Increased Rectal Mucosal Inflammatory Cytokines, Regardless of HIV-1 Serostatus.

Fulcher JA, Shoptaw S, Makgoeng SB, Elliott J, Ibarrondo FJ, Ragsdale A, Brookmeyer R, Anton PA, Gorbach PM.

J Acquir Immune Defic Syndr. 2018 May 1;78(1):119-123. doi: 10.1097/QAI.0000000000001643.

16.

Human Semen or Seminal Plasma Does Not Enhance HIV-1BaL Ex Vivo Infection of Human Colonic Explants.

Kordy K, Elliott J, Tanner K, Johnson EJ, McGowan IM, Anton PA.

AIDS Res Hum Retroviruses. 2018 May;34(5):459-466. doi: 10.1089/AID.2017.0118. Epub 2018 Feb 21.

17.

Maillard reaction products from highly heated food prevent mast cell number increase and inflammation in a mouse model of colitis.

Al Amir I, Dubayle D, Héron A, Delayre-Orthez C, Anton PM.

Nutr Res. 2017 Dec;48:26-32. doi: 10.1016/j.nutres.2017.10.005. Epub 2017 Oct 10.

PMID:
29246278
18.

Repeated Oral Exposure to N ε-Carboxymethyllysine, a Maillard Reaction Product, Alleviates Gut Microbiota Dysbiosis in Colitic Mice.

ALJahdali N, Gadonna-Widehem P, Delayre-Orthez C, Marier D, Garnier B, Carbonero F, Anton PM.

Dig Dis Sci. 2017 Dec;62(12):3370-3384. doi: 10.1007/s10620-017-4767-8. Epub 2017 Sep 30.

PMID:
28965192
19.

Distinct aging profiles of CD8+ T cells in blood versus gastrointestinal mucosal compartments.

Dock J, Ramirez CM, Hultin L, Hausner MA, Hultin P, Elliott J, Yang OO, Anton PA, Jamieson BD, Effros RB.

PLoS One. 2017 Aug 23;12(8):e0182498. doi: 10.1371/journal.pone.0182498. eCollection 2017.

20.

Fecal excretion of Maillard reaction products and the gut microbiota composition of rats fed with bread crust or bread crumb.

Helou C, Anton PM, Niquet-Léridon C, Spatz M, Tessier FJ, Gadonna-Widehem P.

Food Funct. 2017 Aug 1;8(8):2722-2730. doi: 10.1039/c7fo00430c. Epub 2017 Jul 20.

PMID:
28725891
21.

Unique microRNA expression in the colonic mucosa during chronic HIV-1 infection.

Fulcher JA, Koukos G, Koutsioumpa M, Elliott J, Drakaki A, Iliopoulos D, Anton PA.

AIDS. 2017 Sep 10;31(14):1925-1934. doi: 10.1097/QAD.0000000000001582.

22.

Physical Activity and Sleep Quality in Breast Cancer Survivors: A Randomized Trial.

Rogers LQ, Courneya KS, Oster RA, Anton PM, Robbs RS, Forero A, McAuley E.

Med Sci Sports Exerc. 2017 Oct;49(10):2009-2015. doi: 10.1249/MSS.0000000000001327.

23.

Highly Human Immunodeficiency Virus-Exposed Seronegative Men Have Lower Mucosal Innate Immune Reactivity.

Fulcher JA, Romas L, Hoffman JC, Elliott J, Saunders T, Burgener AD, Anton PA, Yang OO.

AIDS Res Hum Retroviruses. 2017 Aug;33(8):788-795. doi: 10.1089/AID.2017.0014. Epub 2017 Jun 19.

24.

Human immune compartment comparisons: Optimization of proliferative assays for blood and gut T lymphocytes.

Dock J, Hultin L, Hultin P, Elliot J, Yang OO, Anton PA, Jamieson BD, Effros RB.

J Immunol Methods. 2017 Jun;445:77-87. doi: 10.1016/j.jim.2017.03.014. Epub 2017 Mar 21.

25.

Analytical Advances in the Ex Vivo Challenge Efficacy Assay.

Richardson-Harman N, Parody R, Anton P, McGowan I, Doncel G, Thurman AR, Herrera C, Kordy K, Fox J, Tanner K, Swartz G, Dezzutti CS.

AIDS Res Hum Retroviruses. 2017 Apr;33(4):395-403. doi: 10.1089/AID.2016.0073. Epub 2016 Dec 16.

26.

Social Cognitive Constructs Did Not Mediate the BEAT Cancer Intervention Effects on Objective Physical Activity Behavior Based on Multivariable Path Analysis.

Rogers LQ, Courneya KS, Anton PM, Hopkins-Price P, Verhulst S, Robbs RS, Vicari SK, McAuley E.

Ann Behav Med. 2017 Apr;51(2):321-326. doi: 10.1007/s12160-016-9840-6.

27.

Effects of a multicomponent physical activity behavior change intervention on breast cancer survivor health status outcomes in a randomized controlled trial.

Rogers LQ, Courneya KS, Carter SJ, Anton PM, Verhulst S, Vicari SK, Robbs RS, McAuley E.

Breast Cancer Res Treat. 2016 Sep;159(2):283-91. doi: 10.1007/s10549-016-3945-2. Epub 2016 Aug 18.

28.

Effects of a multicomponent physical activity behavior change intervention on fatigue, anxiety, and depressive symptomatology in breast cancer survivors: randomized trial.

Rogers LQ, Courneya KS, Anton PM, Verhulst S, Vicari SK, Robbs RS, McAuley E.

Psychooncology. 2017 Nov;26(11):1901-1906. doi: 10.1002/pon.4254. Epub 2016 Sep 6.

29.

Lower rate-pressure product during submaximal walking: a link to fatigue improvement following a physical activity intervention among breast cancer survivors.

Carter SJ, Hunter GR, McAuley E, Courneya KS, Anton PM, Rogers LQ.

J Cancer Surviv. 2016 Oct;10(5):927-34. doi: 10.1007/s11764-016-0539-2. Epub 2016 Apr 9.

30.

Measures to Assure that Ebola Guidelines Are Correctly Applied.

Mira JJ, Asencio-Aznar A, Gea T, Lorenzo S, Antón P.

Med Princ Pract. 2016;25(2):191-5. doi: 10.1159/000441793. Epub 2015 Nov 26.

31.

MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer.

García-García C, Rivas MA, Ibrahim YH, Calvo MT, Gris-Oliver A, Rodríguez O, Grueso J, Antón P, Guzmán M, Aura C, Nuciforo P, Jessen K, Argilés G, Dienstmann R, Bertotti A, Trusolino L, Matito J, Vivancos A, Chicote I, Palmer HG, Tabernero J, Scaltriti M, Baselga J, Serra V.

Clin Cancer Res. 2015 Dec 15;21(24):5499-5510. doi: 10.1158/1078-0432.CCR-14-3091. Epub 2015 Aug 13. Erratum in: Clin Cancer Res. 2016 Aug 1;22(15):3982.

32.

Simultaneous Evaluation of Safety, Acceptability, Pericoital Kinetics, and Ex Vivo Pharmacodynamics Comparing Four Rectal Microbicide Vehicle Candidates.

Leyva F, Fuchs EJ, Bakshi R, Carballo-Dieguez A, Ventuneac A, Yue C, Caffo B, Du Y, Torbenson M, Li L, Mullin G, Lee L, Rohan L, Anton PA, Hendrix CW.

AIDS Res Hum Retroviruses. 2015 Nov;31(11):1089-97. doi: 10.1089/AID.2015.0086. Epub 2015 Jul 8.

33.

MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.

Polytarchou C, Hommes DW, Palumbo T, Hatziapostolou M, Koutsioumpa M, Koukos G, van der Meulen-de Jong AE, Oikonomopoulos A, van Deen WK, Vorvis C, Serebrennikova OB, Birli E, Choi J, Chang L, Anton PA, Tsichlis PN, Pothoulakis C, Verspaget HW, Iliopoulos D.

Gastroenterology. 2015 Oct;149(4):981-92.e11. doi: 10.1053/j.gastro.2015.05.057. Epub 2015 Jun 6.

34.

Exploring the feasibility of multi-site flow cytometric processing of gut associated lymphoid tissue with centralized data analysis for multi-site clinical trials.

McGowan I, Anton PA, Elliott J, Cranston RD, Duffill K, Althouse AD, Hawkins KL, De Rosa SC.

PLoS One. 2015 May 26;10(5):e0126454. doi: 10.1371/journal.pone.0126454. eCollection 2015.

35.

A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study).

Mcgowan I, Cranston RD, Duffill K, Siegel A, Engstrom JC, Nikiforov A, Jacobson C, Rehman KK, Elliott J, Khanukhova E, Abebe K, Mauck C, Spiegel HM, Dezzutti CS, Rohan LC, Marzinke MA, Hiruy H, Hendrix CW, Richardson-Harman N, Anton PA.

PLoS One. 2015 May 5;10(5):e0125363. doi: 10.1371/journal.pone.0125363. eCollection 2015.

36.

T lymphocyte density and distribution in human colorectal mucosa, and inefficiency of current cell isolation protocols.

Preza GC, Yang OO, Elliott J, Anton PA, Ochoa MT.

PLoS One. 2015 Apr 9;10(4):e0122723. doi: 10.1371/journal.pone.0122723. eCollection 2015.

37.

[Help tools for the safe treatment of Ebola in emergency departments].

Mira JJ, Diaz E, Gea T, Antón P.

Rev Calid Asist. 2015 May-Jun;30(3):129-34. doi: 10.1016/j.cali.2015.02.006. Epub 2015 Apr 2. Spanish.

PMID:
25843347
38.

Multiparametric temporal analysis of the Caco-2/TC7 demonstrated functional and differentiated monolayers as early as 14 days of culture.

Zeller P, Bricks T, Vidal G, Jacques S, Anton PM, Leclerc E.

Eur J Pharm Sci. 2015 May 25;72:1-11. doi: 10.1016/j.ejps.2015.02.013. Epub 2015 Feb 25.

PMID:
25725134
39.

Effects of the BEAT Cancer physical activity behavior change intervention on physical activity, aerobic fitness, and quality of life in breast cancer survivors: a multicenter randomized controlled trial.

Rogers LQ, Courneya KS, Anton PM, Hopkins-Price P, Verhulst S, Vicari SK, Robbs RS, Mocharnuk R, McAuley E.

Breast Cancer Res Treat. 2015 Jan;149(1):109-19. doi: 10.1007/s10549-014-3216-z. Epub 2014 Nov 23.

40.

Order of orifices: sequence of condom use and ejaculation by orifice during anal intercourse among women: implications for HIV transmission.

Gorbach PM, Pines H, Javanbakht M, Weiss RE, Jeffries R, Cranston RD, Fuchs EJ, Hezerah M, Brown S, Voskanian A, Anton P.

J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):424-9. doi: 10.1097/QAI.0000000000000314.

41.

Correlation between compartmental tenofovir concentrations and an ex vivo rectal biopsy model of tissue infectibility in the RMP-02/MTN-006 phase 1 study.

Richardson-Harman N, Hendrix CW, Bumpus NN, Mauck C, Cranston RD, Yang K, Elliott J, Tanner K, McGowan I, Kashuba A, Anton PA.

PLoS One. 2014 Oct 28;9(10):e111507. doi: 10.1371/journal.pone.0111507. eCollection 2014.

42.

A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarate.

Yang KH, Hendrix C, Bumpus N, Elliott J, Tanner K, Mauck C, Cranston R, McGowan I, Richardson-Harman N, Anton PA, Kashuba AD.

PLoS One. 2014 Oct 28;9(10):e106196. doi: 10.1371/journal.pone.0106196. eCollection 2014.

43.

Seminal plasma HIV-1 RNA concentration is strongly associated with altered levels of seminal plasma interferon-γ, interleukin-17, and interleukin-5.

Hoffman JC, Anton PA, Baldwin GC, Elliott J, Anisman-Posner D, Tanner K, Grogan T, Elashoff D, Sugar C, Yang OO, Hoffman RM.

AIDS Res Hum Retroviruses. 2014 Nov;30(11):1082-8. doi: 10.1089/AID.2013.0217. Epub 2014 Oct 2.

44.

Rectal-specific microbicide applicator: evaluation and comparison with a vaginal applicator used rectally.

Carballo-Diéguez A, Giguere R, Dolezal C, Bauermeister J, Leu CS, Valladares J, Rohan LC, Anton PA, Cranston RD, Febo I, Mayer K, McGowan I.

AIDS Behav. 2014 Sep;18(9):1734-45. doi: 10.1007/s10461-014-0793-0.

45.

Mucosal gene therapy using a pseudotyped lentivirus vector encoding murine interleukin-10 (mIL-10) suppresses the development and relapse of experimental murine colitis.

Matsumoto H, Haga K, Ohno I, Hiraoka K, Kimura T, Hermann K, Kasahara N, Anton P, McGowan I.

BMC Gastroenterol. 2014 Apr 8;14:68. doi: 10.1186/1471-230X-14-68.

46.

Development of a new microfluidic platform integrating co-cultures of intestinal and liver cell lines.

Bricks T, Paullier P, Legendre A, Fleury MJ, Zeller P, Merlier F, Anton PM, Leclerc E.

Toxicol In Vitro. 2014 Aug;28(5):885-95. doi: 10.1016/j.tiv.2014.02.005. Epub 2014 Mar 22.

PMID:
24662032
47.

Differential blood and mucosal immune responses against an HIV-1 vaccine administered via inguinal or deltoid injection.

Yang OO, Ibarrondo FJ, Price C, Hultin LE, Elliott J, Hultin PM, Shih R, Hausner MA, Ng HL, Hoffman J, Jamieson BD, Anton PA.

PLoS One. 2014 Feb 18;9(2):e88621. doi: 10.1371/journal.pone.0088621. eCollection 2014.

48.

HIV Infection is associated with compositional and functional shifts in the rectal mucosal microbiota.

McHardy IH, Li X, Tong M, Ruegger P, Jacobs J, Borneman J, Anton P, Braun J.

Microbiome. 2013 Oct 12;1(1):26. doi: 10.1186/2049-2618-1-26.

49.

Antigen-presenting cell candidates for HIV-1 transmission in human distal colonic mucosa defined by CD207 dendritic cells and CD209 macrophages.

Preza GC, Tanner K, Elliott J, Yang OO, Anton PA, Ochoa MT.

AIDS Res Hum Retroviruses. 2014 Mar;30(3):241-9. doi: 10.1089/AID.2013.0145. Epub 2013 Dec 10.

50.

HIV-1 Nef sequence and functional compartmentalization in the gut is not due to differential cytotoxic T lymphocyte selective pressure.

Lewis MJ, Frohnen P, Ibarrondo FJ, Reed D, Iyer V, Ng HL, Elliott J, Yang OO, Anton P.

PLoS One. 2013 Sep 13;8(9):e75620. doi: 10.1371/journal.pone.0075620. eCollection 2013.

Supplemental Content

Support Center